| Date Filed | Type | Description |
| 09/10/2018 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 09/07/2018 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 0% stake in SteadyMed Ltd. |
| 09/07/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/07/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/07/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/30/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/30/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/30/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/30/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/30/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/30/2018 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 08/30/2018 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 08/14/2018 |
10-Q
| Quarterly Report for the period ended June 30, 2018 |
| 08/14/2018 |
8-K
| Quarterly results |
| 08/14/2018 |
GN
| SteadyMed Provides Corporate Update and Reports Second Quarter 2018 Financial Results |
| 08/10/2018 |
SC 13G/A
| FEDERATED INVESTORS INC reports a 3.1% stake in STEADYMED, LTD. |
| 08/01/2018 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 07/31/2018 |
GN
| SteadyMed Shareholders Approve Proposed Acquisition by United Therapeutics |
| 07/30/2018 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 5.5% stake in SteadyMed Ltd. |
| 07/20/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/20/2018 |
GN
| HSR Act Waiting Period Terminated for United Therapeutics' Acquisition of SteadyMed Ltd. |
| 07/16/2018 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 06/29/2018 |
8-K
| Other Events |
| 06/29/2018 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 06/25/2018 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 06/08/2018 |
SC 13G/A
| FEDERATED INVESTORS INC reports a 8.1% stake in STEADYMED, LTD. |
| 06/07/2018 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 05/11/2018 |
SC 13G
| Stonepine Capital Management, LLC reports a 5.2% stake in SteadyMed Ltd. |
| 05/07/2018 |
SC 13D
| UNITED THERAPEUTICS Corp reports a 43.3% stake in SteadyMed Ltd. |
| 05/01/2018 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 13.9% stake in SteadyMed Ltd. |
| 04/30/2018 |
8-K
| Quarterly results |
| 04/30/2018 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/30/2018 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/30/2018 |
GN
| United Therapeutics to Acquire SteadyMed Ltd. |
|